• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repare Therapeutics Inc. - Common Shares (NQ:RPTX)

1.860 -0.040 (-2.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 230,794
Open 1.910
Bid (Size) 1.800 (64)
Ask (Size) 1.890 (1)
Prev. Close 1.900
Today's Range 1.800 - 1.940
52wk Range 0.8900 - 4.069
Shares Outstanding 42,088,446
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 13, 2025
From Repare Therapeutics Inc.
Via Business Wire
Repare (RPTX) Q2 Loss Narrows 52%
August 08, 2025
Via The Motley Fool

Performance

YTD
+40.9%
+40.9%
1 Month
+6.9%
+6.9%
3 Month
+22.4%
+22.4%
6 Month
+55.0%
+55.0%
1 Year
-45.6%
-45.6%

More News

Read More
Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
August 08, 2025
From Repare Therapeutics Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 16, 2025
Via Benzinga
Repare Therapeutics Jumps After Hours On $267M Global Licensing Deal With Debiopharm; Retail Traders Rush In
July 16, 2025
Via Stocktwits
Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket
July 16, 2025
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 15, 2025
Via Benzinga
Tuesday's after hours session: top gainers and losers
July 15, 2025
Via Chartmill
Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib
July 15, 2025
From Repare Therapeutics Inc.
Via Business Wire
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
May 13, 2025
From Repare Therapeutics Inc.
Via Business Wire
Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
May 01, 2025
From Repare Therapeutics Inc.
Via Business Wire
Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
April 25, 2025
From Repare Therapeutics Inc.
Via Business Wire
Cathie Wood's Ark Invest Offloads Uipath, Prime Medicine, And Repare Therapeutics
April 11, 2025
Via Benzinga
Cathie Wood's Ark Invest Loads Up On Amazon, Coinbase: Offloads UiPath, Roblox
April 04, 2025
Via Benzinga
Cathie Wood Doubles Down: Mops Up Another $1.39 Million Worth Of Robinhood Stock Amid Trump Tariff Dip
April 03, 2025
Via Benzinga
Topics Government
Repare Therapeutics Announces Leadership Transitions
March 31, 2025
From Repare Therapeutics Inc.
Via Business Wire
Cathie Wood's Ark Invest Loads Up On Robinhood, Nvidia-Backed CoreWeave: Offloads Spotify, Roku
March 29, 2025
Via Benzinga
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
March 22, 2025
Via Benzinga
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta
March 15, 2025
Via Benzinga
Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 07, 2025
From Repare Therapeutics Inc.
Via Business Wire
Gap To Rally Over 69%? Here Are 10 Top Analyst Forecasts For Friday
March 07, 2025
Via Benzinga
Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results
March 03, 2025
From Repare Therapeutics Inc.
Via Business Wire
Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions
January 09, 2025
From Repare Therapeutics Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 13, 2024
Via Benzinga
Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet
December 13, 2024
Via Benzinga

Frequently Asked Questions

Is Repare Therapeutics Inc. - Common Shares publicly traded?
Yes, Repare Therapeutics Inc. - Common Shares is publicly traded.
What exchange does Repare Therapeutics Inc. - Common Shares trade on?
Repare Therapeutics Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Repare Therapeutics Inc. - Common Shares?
The ticker symbol for Repare Therapeutics Inc. - Common Shares is RPTX on the Nasdaq Stock Market
What is the current price of Repare Therapeutics Inc. - Common Shares?
The current price of Repare Therapeutics Inc. - Common Shares is 1.860
When was Repare Therapeutics Inc. - Common Shares last traded?
The last trade of Repare Therapeutics Inc. - Common Shares was at 10/16/25 04:00 PM ET
What is the market capitalization of Repare Therapeutics Inc. - Common Shares?
The market capitalization of Repare Therapeutics Inc. - Common Shares is 78.28M
How many shares of Repare Therapeutics Inc. - Common Shares are outstanding?
Repare Therapeutics Inc. - Common Shares has 78M shares outstanding.
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap